2026 Market Outlook: Why A Small Slice Of AI Defense Can Pay Off

Group 1 - Major Wall Street strategists forecast that the S&P 500 will finish 2026 significantly above current levels, with targets ranging from 7,400 to 8,100 [1] Group 2 - The focus is on identifying promising biotechnology companies that are innovating through novel mechanisms of action, first-in-class therapies, or platform technologies [1] - The analysis emphasizes evaluating the science behind drug candidates, the competitive landscape, clinical trial design, and potential market opportunities while balancing financial fundamentals and valuation [1]